Full Text
Cost-Effectiveness Analysis of Brentuximab Vedotin in Adults with Relapsed or Refractory Hodgkin’s Lymphoma

Abstract

Authors

GR Khachatryan D Fedyaev M Avxentyeva VS Dombrovskiy

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×